Annual Report

Overview

The report describes Otsuka Holdings' FY2016 consolidated net sales of ¥1,195.5 billion and operating profit of ¥101.1 billion, while highlighting growth in global pharmaceutical products including REXULTI, Samsca/JINARC, and LONSURF. It reports nutraceutical business net sales of ¥311.6 billion and notes that higher sales growth outside Japan supported the business's performance and profit margins. The CSR section features community health and education programs and a 2016 initiative in Indonesia that planted 12,500 pine trees.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services